Advanced Proteome Therapeutics Corporation Stock
Equities
APC.H
CA0076282098
Investment Holding Companies
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
0.005 CAD | -.--% | -.--% | -.--% |
Sales 2021 | - | Sales 2022 | - | Capitalization | 4.65M 6.36M |
---|---|---|---|---|---|
Net income 2021 | -1M -1.37M | Net income 2022 | - 0 | EV / Sales 2021 | - |
Net cash position 2021 | 324K 443K | Net cash position 2022 | 31.61K 43.25K | EV / Sales 2022 | - |
P/E ratio 2021 |
-4.85
x | P/E ratio 2022 |
6.03
x | Employees | - |
Yield 2021 * |
-
| Yield 2022 |
-
| Free-Float | 89.84% |
6 months | -50.00% |
Managers | Title | Age | Since |
---|---|---|---|
Paul Woodward
CEO | Chief Executive Officer | 63 | 18-04-15 |
Ken Phillippe
DFI | Director of Finance/CFO | 72 | 09-03-09 |
Martin Woodward
BRD | Director/Board Member | 56 | 18-12-19 |
Members of the board | Title | Age | Since |
---|---|---|---|
W. Catalano
BRD | Director/Board Member | 59 | - |
Martin Woodward
BRD | Director/Board Member | 56 | 18-12-19 |
Cory Brandolini
BRD | Director/Board Member | 64 | 22-11-20 |
1st Jan change | Capi. | |
---|---|---|
-.--% | 150K | |
+173.89% | 6.55B | |
+5.57% | 1.05B | |
+2.29% | 983M | |
+41.91% | 872M | |
+20.36% | 786M | |
+1.72% | 664M | |
+40.25% | 639M | |
-.--% | 600M | |
-2.15% | 593M |
- Stock Market
- Equities
- APC.H Stock